BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, June 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 11, 2019
View Archived Issues
New antibody against F glycoprotein prevents membrane fusion and viral entry in NiV, HeV infections
Read More
Novel dietary-induced mouse model of NASH with severe fibrosis
Read More
Celldex reports results from ongoing phase I study of CDX-1140
Read More
Enrollment ongoing in phase III study of TV P2-VP8 vaccine
Read More
Pfizer initiates phase III study of PF-06741086
Read More
Phase IIb ATLAS study of etokimab fails to meet the primary endpoint
Read More
Update given for the phase III JAVELIN gastric 100 trial
Read More
UMC Utrecht Holding discloses thombolytic fusion proteins
Read More
IL-38 protein compositions described by Reyoung Suzhou Biology Science & Technology
Read More
FORMA Therapeutics discovers histone deacetylase 11 inhibitors
Read More
Medshine Discovery patents Rho kinase inhibitors
Read More
Roche and Genentech identify new RIP-1 inhibitors
Read More
Simpler recipe makes better cocktail for iPSCs
Read More
Exosomes help brain metastases along
Read More
Novel AVV-based vector therapy for the treatment of AD
Read More
New DREADD tools for noninvasive manipulation and visualization of neuronal circuits in animals
Read More
Zelluna Immunotherapy presents novel compound, ZI-H04, as cancer immunotherapeutic
Read More
Glecaprevir/pibrentasvir investigated in young children with chronic HCV infection
Read More
Now, Sleeping Beauty is the fairest of them all
Read More
NKTR-358 safe and well tolerated in first-in-human study
Read More
SUNFISH study of risdiplam in type 2 and 3 SMA meets primary endpoint
Read More
FDA approves Reblozyl for anemia in beta thalassemia requiring regular RBC transfusions
Read More
First-in-human comparison of LY-2775240 and apremilast in healthy volunteers
Read More
New phase IIa study investigates use of MTPS-9579A in asthma
Read More
Lyvgen initiates first-in-human study of LVGN-6051 in advanced or metastatic malignancy
Read More
Roche announces discontinuation of RG-6206 development in DMD
Read More
Oncogene-linked prodrug strategy for selective KEAP1 mutant NSCLC cytotoxicity
Read More
